On 4 February, GlaxoSmithKline (GSK) announced that it planned to pull ... and private foundations to take stock. But the biggest problem, researchers say, is that there is almost nothing in the pipeline that gives any hope for a …
H1N1 swine flu vaccine maker GlaxoSmithKline released its fourth quarter profits ... with the majority of those sales coming in the first quarter of the year. The company’s stock has declined 2.5 per cent over the last 12 months.
GlaxoSmithKline’s North American head Chris Viehbacher, who was in the running to replace Jean-Pierre Garnier as chief executive last year, is leaving the company. Mr Viehbacher, who held the posts of executive director and …
DALLAS--(BUSINESS WIRE)--Investment opinion and research company InvestorSoup.com announces the availability …
Existing labelled stock may still have the previously approved ... 14 May 2012: Update on two-dose presentation of preservative-free 10-valent pneumococcal conjugate vaccine from GlaxoSmithKline (GSK) (Synflorix™). 30 April …
WHO7y
Key highlights this week include FDA approval of two highly-awaited drugs -- Sanofi SNY and Regeneron’s Dupixent and Roche’s RHHBY Ocrevus. Both drugs have blockbuster potential. Meanwhile, Mylan MYL got a complete response …
Yahoo!9mon
Mumbai: GlaxoSmithKline (GSK) will scrap the traditional appraisal system of its employees in favour of a new performance management mechanism, which includes regular dialogue and feedback. Called 'My Plan', the mechanism …
An experimental drug for rheumatoid arthritis developed by Johnson & Johnson and GlaxoSmithKline slowed joint damage and improved symptoms of the disease, meeting the main goals of a large, late stage trial, according to data …
Both strengths will be administered once-daily using Ellipta, a new dry powder inhaler (DPI). Darrell Baker, SVP & Head, GSK Global Respiratory Franchise, said, "For many years GSK has been focused on developing a portfolio of new …
China has fined the British pharmaceuticals giant GlaxoSmithKline (GSK) $488.8 million (3 billion Yuan) for a "massive bribery network" to get doctors and hospitals to use its products. Five former employees were sentenced to two to four …